Product/Composition:- | Tenofovir & Emtricitabine |
---|---|
Strength:- | Tenofovir DF 300 mg + Emtricitabine 200 mg |
Form:- | Tablet |
Reference Brands:- | Truvada®(US/EU) |
MOQ | As per the manufacturer batch size |
Get Quote Send Enquiry on WhatsApp |
Tenofovir & Emtricitabine Tablets (300/200 mg) are key antiretrovirals for HIV treatment and PrEP. Available under brands like Truvada® and Tenvir-EM®, they can be sourced in bulk via PharmaB2B from WHO-GMP suppliers. Ideal for NGOs, tenders, and global HIV programs seeking reliable ARV access.
Tenofovir & Emtricitabine Tablets (300 mg/200 mg), marketed under brands like Truvada®, Tenvir-EM®, and Ricovir-EM®, are WHO-recommended antiretrovirals used for both HIV-1 treatment and pre-exposure prophylaxis (PrEP). This fixed-dose, once-daily combination offers high efficacy with a strong safety profile. On PharmaB2B platforms, global buyers, NGOs, and procurement agencies can source WHO-GMP and USFDA-approved formulations in bulk from trusted manufacturers. Ideal for HIV prevention programs, public health supply chains, and international tenders, Tenofovir + Emtricitabine supports global access to affordable, life-saving HIV care. Partner with reliable suppliers for consistent, quality-assured ARV supply.